Skip to content

Clinical trials

Phase 2 Ischemic Stroke trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 2 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20041
20061
20071
20101
20121
20131
20191
20201
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Recruiting2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc2
University of Alberta2
University of Calgary2
ARCA Biopharma, Inc.1
AbbVie1
Basking Biosciences, Inc.1
Bayer1
Bristol-Myers Squibb1
Dongzhimen Hospital, Beijing1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke17
Stroke9
Thrombosis2
Atrial Fibrillation1
Cerebral Small Vessel Diseases1
Intracranial Hemorrhages1
Ischemic Attack, Transient1
Myocardial Infarction1
Venous Thromboembolism1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.